Iomeron (Iomeprol)

Iomeprol is a high‑iodine compound; each molecule carries several iodine atoms that strongly absorb X‑ray photons. After intravenous or intra‑arterial injection, the iodine distributes within the vascular and extracellular spaces, temporarily raising the radiodensity of those areas. This contrast difference allows imaging systems to differentiate tissues and vascular structures more clearly.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function and the required level of contrast enhancement. Dosing guidelines are provided in the product’s prescribing information, and the healthcare professional selects the appropriate volume for each procedure.

The safety of Iomeron during pregnancy and lactation has not been definitively established. Iodinated contrast agents cross the placenta and may affect fetal thyroid function, and small amounts can be excreted in breast milk. Use is generally reserved for situations where the diagnostic benefit outweighs potential risks, and clinicians should consult current guidelines.

To place an order, visit the product page on gnhindia.com, enter the desired quantity of Iomeron, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including any required cold‑chain handling—and assists with import documentation.

Iomeron (iomeprol) is a non‑ionic, low‑osmolality iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents that were associated with higher rates of adverse reactions. Compared with other low‑osmolality agents, its iodine concentration and viscosity are similar, providing comparable image quality while reducing the risk of discomfort and renal effects.

Iomeron should be stored at controlled room temperature, below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture and extreme temperatures. Before use, inspect the vial for particulate matter or discoloration, and avoid shaking the product vigorously. Follow standard aseptic techniques when preparing the injection.

Iomeron is supplied as a sterile solution for injection and is administered intravenously or intra‑arterially by a qualified healthcare professional. The injection is typically performed using a power injector or manual bolus, following the imaging protocol’s recommended volume and rate. Proper catheter placement and patient monitoring are essential during administration.

The most serious risks include acute allergic or anaphylactoid reactions, which can manifest as urticaria, bronchospasm or cardiovascular collapse, and contrast‑induced nephropathy leading to acute kidney injury, especially in patients with pre‑existing renal impairment. Severe hypotension and cardiac arrhythmias may also occur, requiring immediate medical intervention.

Iomeron is contraindicated in patients with a known hypersensitivity to iomeprol or any iodinated contrast media, as well as those with uncontrolled hyperthyroidism where excess iodine could exacerbate the condition. Caution is advised in individuals with severe renal insufficiency, recent use of nephrotoxic drugs, or those who are pregnant or breastfeeding unless the diagnostic benefit justifies the potential risk.